Resistance and viral subtypes: how important are the differences and why do they occur?

@article{Brenner2007ResistanceAV,
  title={Resistance and viral subtypes: how important are the differences and why do they occur?},
  author={Bluma G Brenner},
  journal={Current opinion in HIV and AIDS},
  year={2007},
  volume={2 2},
  pages={94-102}
}
PURPOSE OF REVIEW The global HIV-1 pandemic has evolved to include 11 subtypes and 34 circulating recombinant forms. Our knowledge of HIV-1 response to antiretroviral drugs and emergent drug resistance has, however, been limited to subtype B infections circulating in Europe and North America, with little comparative information on non-B subtypes representing approximately 90% of worldwide epidemics. This review summarizes publications in the past year that highlight intersubtype differences… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 77 references

Natural polymorphisms in the HIV - 2 protease can accelerate time to development of resistance to protease inhibitors ( PIs ) ( in press )

  • M Ntemgwa, BG Brenner, M Oliveira
  • Antimicrob Agents Chemother
  • 2007

Biological characterization of human immunodeficiency virus type 1 subtype C protease carrying indinavir drugresistance mutations

  • Gonzalez LMF, RS Aguiar, A Afonso
  • J Gen Virol
  • 2006

Similar Papers

Loading similar papers…